CD109 expression in squamous cell carcinoma of the uterine cervix.
about
CD109 plays a role in osteoclastogenesisCandidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells.CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.Suppression of skin tumorigenesis in CD109-deficient mice.Prognostic impact of CD109 expression in myxofibrosarcoma.CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.Detection of differentially expressed genes and association with clinicopathological features in laryngeal squamous cell carcinoma.Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.CD109 expression in basal-like breast carcinoma.High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.CD109 expression is upregulated in penile squamous cell carcinoma.Myxofibrosarcoma primary cultures: molecular and pharmacological profile.Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.CD109 and squamous cell carcinoma.
P2860
Q28505691-538ACF93-1F76-4FCA-810F-004B2715C012Q33933054-345105D4-3910-4748-9166-D2CFE73DFCDAQ34088459-CEB78539-E517-4B39-A89F-7EFA2C185D91Q34627087-570F5996-C516-4485-9AD4-78E2D6B1D962Q36246124-894321AD-B9C7-4A50-9C0C-14AFBF2CC1ADQ36925909-BF360DFF-6D58-4ADA-9B07-A14774E0B97CQ37439207-B45624B5-6448-4FBF-A976-263370ABA643Q37696223-6E4BF729-B2B6-4066-AAB9-E3F63DF315C2Q38386065-51DC0C85-B537-4FF7-8371-579D80AA6D4BQ39478295-C70A7FE4-3A98-4772-BB69-BB94724A22F3Q39505892-B280E810-9AEB-4533-95D5-B2FCFDA7F09EQ39747986-9854F90C-B977-49F1-9A8C-33B2DA3DABCDQ42170620-BD47B76B-BAD8-4F40-AE2D-057965CD5795Q42519941-DDA93AA2-EA59-4B60-B551-16A0F9FE9779Q42738187-5297C8C9-C097-4181-BB13-C711276C1149Q43269447-D2D25C08-B39D-4BDC-8E21-3B2FC8C3C546Q49956275-757ADE35-857D-4E31-96E0-9EDAA6E59246Q55004536-FD239A87-8090-4EE5-AFDC-2212C59B01D9Q55025939-CE7A9881-54A2-486F-853D-03AC33BD5822
P2860
CD109 expression in squamous cell carcinoma of the uterine cervix.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
CD109 expression in squamous cell carcinoma of the uterine cervix.
@ast
CD109 expression in squamous cell carcinoma of the uterine cervix.
@en
CD109 expression in squamous cell carcinoma of the uterine cervix.
@nl
type
label
CD109 expression in squamous cell carcinoma of the uterine cervix.
@ast
CD109 expression in squamous cell carcinoma of the uterine cervix.
@en
CD109 expression in squamous cell carcinoma of the uterine cervix.
@nl
prefLabel
CD109 expression in squamous cell carcinoma of the uterine cervix.
@ast
CD109 expression in squamous cell carcinoma of the uterine cervix.
@en
CD109 expression in squamous cell carcinoma of the uterine cervix.
@nl
P2093
P2860
P1476
CD109 expression in squamous cell carcinoma of the uterine cervix.
@en
P2093
Jing-Min Zhang
Kumi Kawai
Masahide Takahashi
Masatoshi Ichihara
Mizuo Hashimoto
Shigeo Nakamura
Tomoko Sato
Yoshiki Murakumo
P2860
P304
P356
10.1111/J.1440-1827.2005.01807.X
P577
2005-04-01T00:00:00Z